| 词条 | Amfonelic acid |
| 释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 477001303 | IUPAC_name = 7-benzyl-1-ethyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid | image = Amfonelic_acid.png | tradename = | legal_status = Uncontrolled | routes_of_administration = | bioavailability = | metabolism = | elimination_half-life = | CAS_number_Ref = {{cascite|changed|??}} | CAS_number = 15180-02-6 | ATC_prefix = none | ATC_suffix = | PubChem = 2137 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 2052 | UNII_Ref = {{fdacite|changed|FDA}} | UNII = RR302AR19Y | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D02897 | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 35337 | C=18 | H=16 | N=2 | O=3 | molecular_weight = 308.3329 g/mol | smiles = CCN1C=C(C(=O)C2=C1N=C(C=C2)CC3=CC=CC=C3)C(=O)O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C18H16N2O3/c1-2-20-11-15(18(22)23)16(21)14-9-8-13(19-17(14)20)10-12-6-4-3-5-7-12/h3-9,11H,2,10H2,1H3,(H,22,23) | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = WHHHJDGNBVQNAU-UHFFFAOYSA-N |drug_name=|alt=|caption=|type=|MedlinePlus=|licence_EU=|pregnancy_AU=|pregnancy_US=|pregnancy_category=|licence_US=|DrugBank=}}Amfonelic acid (AFA; WIN 25,978) is a research chemical and dopaminergic stimulant with antibiotic properties.[1] HistoryThe stimulant properties of AFA were discovered serendipitously at Sterling-Winthrop in the midst of research on the antibiotic nalidixic acid.[1] In addition to behaving as antibiotics, it was found that many derivatives of nalidixic acid have either stimulant or depressant effects on the central nervous system.[2] Researchers at Sterling-Winthrop found that AFA had a higher potency and therapeutic index than cocaine or amphetamine and so it was singled out for further study.[1][3] A small number of clinical trials were held in the 1970s, but when it was found that AFA exacerbated psychotic symptoms in schizophrenic patients and produced undesirable stimulant properties in geriatric depressives clinical evaluation of AFA was discontinued.[1] AFA remains a widely used pharmacological tool for study of the brain's reward system, dopamine pathways, and the dopamine transporter.[1] Since 2013 AFA has been sold on the gray market and there are numerous anecdotal reports detailing its non-medical use.[1] PharmacologyIn studies it proved to be a potent and highly selective dopamine reuptake inhibitor (DRI) in rat brain preparations.[4][5] A study found a moderately long half-life of approximately 12 hours and a dopaminergic potency approximately 50 fold that of methylphenidate in rat brain preparations.[6] Despite lack of direct serotonin activity, rats treated with subchronic doses of amfonelic acid display subsequent decreases in 5HT and 5HIAA.[7] Amfonelic acid displays no activity in the norepinephrine system.[8] Despite its different mechanism of action, amfonelic acid displays discriminatory substitution with 150% the stimulant potency of dextroamphetamine.[9] Amfonelic acid has been shown to be neuroprotective against methamphetamine damage to dopamine neurons.[10] It also increases the effects of the antipsychotic drugs haloperidol, trifluoperazine and spiperone.[11] Rats are shown to self-administer amfonelic acid in a dose-dependent manner.[12] Though AFA was discovered in the course of antibiotic research, there is very little data available on the drug's antimicrobial activity. In 1988 the biologist G.C. Crumplin wrote, "[AFA] is less active against bacteria than are many other 4-quinolones, but studies in our laboratory on selected mammalian cell lines have shown it to be markedly more toxic to these cells than are the 4-quinolones that are more active antibacterial agents. Furthermore, it can be shown that sublethal doses induced marked changes in the pattern of proteins produced by the cell, thus suggesting a possible effect of 4-quinolones on gene transcription in mammalian cells."[13] When evaluated via broth microdilution the MIC of AFA for Escherichia coli is 125 μg/mL, a concentration thirty times higher than the MIC for nalidixic acid in the same E. coli strain.[1] See also
References1. ^1 2 3 4 5 6 {{cite web|url=http://harpers.org/archive/2015/10/sad-pink-monkey-blues/ |title=Sad Pink Monkey Blues |last=Morris, Hamilton |publisher=Harper's Magazine |date=October 2015 |accessdate=2015-09-19}} 2. ^{{ cite patent | country = US | status = patent | number = 3590036 | title = Naphthyridine-3-carboxylic Acids, Their Derivatives and Preparation Thereof }} 3. ^{{Cite journal|pmid=4393073|year=1970|last1=Aceto|first1=M.A.|title=Pharmacologic properties and mechanism of action of amfonelic acid|pages=344–354|journal=European Journal of Pharmacology|doi=10.1016/0014-2999(70)90206-2|volume=10|issue=3}} 4. ^{{ cite journal |author1=Fuller, R. W. |author2=Perry, K. W. |author3=Bymaster, F. P. |author4=Wong, D. T. | title = Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4-dihydroxyphenylacetic acid concentration in spiperone-treated rats. | journal = Journal of Pharmacy and Pharmacology | volume = 30 | issue = 3 | pages = 197–198 | year = 1978 | pmid = 24701 | doi = 10.1111/j.2042-7158.1978.tb13201.x }} 5. ^{{ cite journal |author1=McMillen, B. A. |author2=Shore, P. A. | title = Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: Association with differences in neuronal storage systems | journal = Journal of Pharmacy and Pharmacology | year = 1978 | volume = 30 | issue = 7 | pages = 464–466 | pmid = 27622 | doi = 10.1111/j.2042-7158.1978.tb13293.x }} 6. ^{{ cite journal |author1=Izenwasser, S. |author2=Werling, L. L. |author3=Cox, B. M. | title = Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex | journal = Brain Research | volume = 520 | issue = 1–2 | pages = 303–309 | year = 1990 | pmid = 2145054 | doi=10.1016/0006-8993(90)91719-W}} 7. ^{{Cite journal|pmid=2018630|year=1991|last1=McMillen|first1=BA|last2=Scott|first2=SM|last3=Williams|first3=HL|title=Effects of subchronic amphetamine or amfonelic acid on rat brain dopaminergic and serotonergic function|volume=83|issue=1–2|pages=55–66|journal=Journal of Neural Transmission. General Section|doi=10.1007/BF01244452}} 8. ^{{Cite journal|pmid=9085190|year=1997|last1=Agmo|first1=A|last2=Belzung|first2=C|last3=Rodríguez|first3=C|title=A rat model of distractibility: Effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission|volume=104|issue=1|pages=11–29|journal=Journal of Neural Transmission|doi=10.1007/BF01271291}} 9. ^{{Cite journal|pmid=6728880|year=1984|last1=Aceto|first1=MD|last2=Rosecrans|first2=JA|last3=Young|first3=R|last4=Glennon|first4=RA|title=Similarity between (+)-amphetamine and amfonelic acid|volume=20|issue=4|pages=635–7|journal=Pharmacology Biochemistry and Behavior|doi=10.1016/0091-3057(84)90316-2}} 10. ^{{Cite journal|pmid=7953636|year=1994|last1=Pu|first1=C|last2=Fisher|first2=JE|last3=Cappon|first3=GD|last4=Vorhees|first4=CV|title=The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum|volume=649|issue=1–2|pages=217–24|journal=Brain Research|doi=10.1016/0006-8993(94)91067-7}} 11. ^{{Cite journal|pmid=2857083|year=1985|last1=Waldmeier|first1=PC|last2=Huber|first2=H|last3=Heinrich|first3=M|last4=Stoecklin|first4=K|title=Discrimination of neuroleptics by means of their interaction with amfonelic acid: An attempt to characterize the test|volume=34|issue=1|pages=39–44|journal=Biochemical Pharmacology|doi=10.1016/0006-2952(85)90097-8}} 12. ^{{Cite journal|pmid=2908003|year=1988|last1=Porrino|first1=LJ|last2=Goodman|first2=NL|last3=Sharpe|first3=LG|title=Intravenous self-administration of the indirect dopaminergic agonist amfonelic acid by rats|volume=31|issue=3|pages=623–6|journal=Pharmacology Biochemistry and Behavior|doi=10.1016/0091-3057(88)90240-7}} 13. ^{{Cite journal|pmid=3279494|year=1988|last1=Crumplin|first1=G.C.|title=Aspects of Chemistry in the Development of the 4-Quinolone Antibacterial Agents |issue=10|pages=S2–S9|journal=Reviews of Infectious Diseases|doi=10.1093/clinids/10.Supplement_1.S2|volume=10 Suppl 1}} External links
7 : Dopamine reuptake inhibitors|WIN compounds|Ketones|Naphthyridines|Carboxylic acids|Euphoriants|Stimulants |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。